Merani Rohan, Johnson Mark W, McCannel Colin A, Flynn Harry W, Scott Ingrid U, Hunyor Alex P
Concord Repatriation General Hospital, Sydney, NSW, Australia.
Save Sight Institute, Specialty of Clinical Ophthalmology and Eye Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
J Vitreoretin Dis. 2022 Sep 8;6(6):443-451. doi: 10.1177/24741264221116487. eCollection 2022 Nov-Dec.
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
尽管玻璃体内注射抗血管内皮生长因子后发生感染性眼内炎较为罕见,但它是该手术最令人担忧且可能具有毁灭性的并发症。目前尚无高级别证据可为玻璃体内注射(IVI)后发生的眼内炎管理提供明确指导。本临床实践更新回顾了关于IVI后眼内炎的已发表文献,并强调了需要进一步研究以更好地指导其管理的领域。